TGFB1 and non-small cell lung carcinoma: Bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, showed manageable safety and efficacy for pretreated non-small cell lung cancer and esophageal squamous cell carcinoma [45, 46].